1-3 of 3
Marcus Geer
Close
Sort by
Journal Articles

Lymphodepleting Chemotherapy before CD19 Directed CAR T-Cell Therapy: Are 3 Days Necessary?

Marcus Geer, Salena Kasha, David Frame, Monalisa Ghosh
Journal: Blood
Blood (2022) 140 (Supplement 1): 3823–3824.
https://doi.org/10.1182/blood-2022-168456
Published: 2022
Journal Articles

Substantial Variation in Peripherally Inserted Central Catheter Use and Outcomes in Patients with Hematologic Malignancies: A Multi-Center Study

Marcus Geer, Urvashi Mitbander, Knut Taxbro, Qisu Zhang, Megan O'Malley, Jennifer Horowitz, Nithya Ramnath, Suman L Sood, Vineet Chopra
Journal: Blood
Blood (2021) 138 (Supplement 1): 4038.
https://doi.org/10.1182/blood-2021-148133
Published: 2021
Journal Articles

Multicenter Retrospective Study of Features and Outcomes of Patients with Intravascular DLBCL Treated at Academic Institutions within the United States

Marcus Geer, MD, Maryann Shango, MD, Brian G. Till, MD, Stephen D. Smith, MD, Hashim Abbas, MD, Brian T. Hill, MD PhD, Jason Kaplan, MD, Paul M. Barr, MD, Paolo Caimi, MD, Deborah M. Stephens, DO, Emily Lin, MD, Alex F. Herrera, MD, Evan Rosenbaum, MD, Jennifer E Amengual, MD, Emily Roberts, Philip S Boonstra, PhD, Sumana Devata, MD, Ryan A. Wilcox, MD, Mark S Kaminski, MD, Tycel J. Phillips, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 377.
https://doi.org/10.1182/blood.V130.Suppl_1.377.377
Published: 2017